Europe Vascular Closure Device Market Forecast to 2030

Europe Vascular Closure Device Market Forecast to 2030 – Regional Analysis – by Product Type (Active Approximators, Passive Approximators, and External Hemostatic Devices), Access (Femoral Access and Radial Access), Procedure (Interventional Cardiology, Interventional Radiology, and Endovascular Surgery), and End User (Hospitals, Ambulatory Surgical Centers, and Others)

Send Enquiry

$2,840$4,440

Description

The Europe vascular closure device market was valued at US$ 362.63 million in 2022 and is expected to reach US$ 621.74 million by 2030; it is estimated to record a CAGR of 7.0% from 2022 to 2030.

Strategic Activities by Manufacturers Drive Europe Vascular Closure Device Market

The medical device industry is developing significantly due to the increasing demand for technologically advanced products. Major market players engage in new product developments, launches, and approvals to ensure the innovation and development of efficient products. A few of the recent product launches and approvals in the vascular closure devices market are mentioned below.
In September 2022, Haemonetics Corporation obtained CE mark certification for its VASCADE and VASCADE MVP venous vascular closure systems. The CE marking allows Haemonetics to engage in the next steps of launching both products into the European Union (EU); it also allows the company to enter into other geographies that recognize CE marking. As of 2021, VASCADE MVP was the first and only FDA-approved vascular closure device indicated for use following atrial fibrillation (AF) ablation to allow same-day discharge.
In September 2023, a cross-seal, suture-mediated vascular closure device system by Terumo Medical Corporation received approval from the FDA. The device is indicated for the percutaneous delivery of sutures for closing a common femoral artery access site while reducing time-to-hemostasis in patients who have undergone diagnostic or interventional catheterization using 8F to 18F sheaths. The Cross-Seal System is indicated for one access site per leg. Such strategic initiatives are likely to emerge as a key trend in the Europe vascular closure device market during the forecast period.

Europe Vascular Closure Device Market Overview

Cardiovascular disorders are among the most common causes of death in Germany. Changing lifestyles among the masses is a major risk factor for this disease. Cardiovascular disorders account for ~40% of deaths in Germany, followed by cancer and diabetes. According to the WHO, the death toll due to coronary heart disease in Germany reached 147,055 (i.e., 20.98% of total mortalities) in 2020. The presence of developed healthcare facilities and the increasing number of minimally invasive cardiology procedures are among the factors that are likely to create demand for vascular closure devices. According to data published in the Burden of Stroke in Europe report prepared by King’s College London for the Stroke Alliance for Europe, Germany records ~88,922 stroke cases annually, which is equivalent to nearly 52 cases per 100,000 inhabitants. The total prevalence of stroke in Germany was 526,774, which accounts for 338.5 strokes per 100,000 residents. Germany also has a significant mortality rate of stroke as it reports 75,861 deaths due to stroke per year. According to the Burden of Stroke in Europe report, stroke cases in Germany are likely to surge by 30% by 2035, while the prevalence of stroke is anticipated to rise to 19% by the end of 2035. Thus, the significantly growing incidence of stroke and cardiovascular disorder drives the vascular closure devices market growth in Germany.

Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Million)

Europe Vascular Closure Device Market Segmentation

The Europe vascular closure device market is segmented based on product type, access, procedure, end user, and country.

Based on product type, the Europe vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share in 2022. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.

By access, the Europe vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held a larger share in 2022.

By procedure, the Europe vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology access segment held the largest share in 2022.

In terms of end user, the Europe vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share in 2022.

Based on country, the Europe vascular closure device market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Rest of Europe dominated the Europe vascular closure device market in 2022.

Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, ENDOCOR GmbH & CO KG, Haemonetics Corp, Medtronic Plc, Teleflex Inc, and Vasorum Ltd are some of the leading companies operating in the Europe vascular closure device market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 7.0% CAGR, Europe Vascular Closure Device Market is Speculated to be Worth US$ 621.74 Million by 2030, Says the Research Team

According to the Research Team’ research, the Europe vascular closure device market was valued at US$ 362.63 million in 2022 and is expected to reach US$ 621.74 million by 2030, registering a CAGR of 7.0% from 2022 to 2030. Increasing prevalence of cardiovascular diseases and strategic activities by manufacturers are among the critical factors attributed to the Europe vascular closure device market expansion.

Cardiovascular diseases such as atherosclerosis, angina pectoris, and acute myocardial infarction are the major causes of mortality in the world. As per data provided by the World Health Organization (WHO), cardiovascular diseases cause nearly 17.9 million deaths every year, which makes it a leading cause of mortality among all noncommunicable diseases, followed by cancer, chronic respiratory diseases, and diabetes (including deaths associated with renal disorders). According to the World Heart Federation, high cholesterol causes 4.4 million deaths yearly, and 24% of cardiovascular-related deaths are associated with high low-density lipoprotein (LDL) levels. Vascular closure devices (VCDs) offer a new way to enhance patients’ comfort and ambulation after invasive cardiovascular treatments via femoral arterial access. Vascular closure devices are used in different therapeutic approaches to provide easy, quick, and reliable hemostasis. In the US, femoral arterial access is the most often used vascular access technique for percutaneous coronary intervention (PCI) and coronary angiography. Nevertheless, there has been an increase in traction toward cardiac catheterization and percutaneous coronary intervention (PCI) via radial access in recent years. Several femoral artery closure devices have been developed to shorten vascular closure times, with variable rates of vascular complications observed in clinical trials. Vascular closure devices (VCDs) have emerged as an effective alternative to traditional mechanical compression procedures performed after cardiac catheterization. VCDs reduce the time of hospital stays, speed up patient mobilization and shorten the time needed to achieve hemostasis. Thus, the Europe vascular closure device market is growing notably with the increasing prevalence of cardiovascular diseases.

On the contrary, risk of infection related to vascular closure devices hampers the growth Europe vascular closure device market.

Based on product type, the Europe vascular closure device market is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held 69.0% share of the Europe vascular closure device market in 2022, amassing US$ 250.20 million. It is projected to garner US$ 433.99 million by 2030 to expand at 7.1% CAGR during 2022-2030. The active approximators segment is further segmented into suture mediated device and staple clips mediated device. The passive approximators segment is further segmented into sealant and gel based, compression devices, and collagen plug.

By access, the Europe vascular closure device market is bifurcated into femoral access and radial access. The femoral access segment held 78.0% share of the Europe vascular closure device market in 2022, amassing US$ 282.88 million. It is projected to garner US$ 481.69 million by 2030 to expand at 6.9% CAGR during 2022-2030.

By procedure, the Europe vascular closure device market is segmented into interventional cardiology, interventional radiology, and endovascular surgery. The interventional cardiology segment held 61.7% share of the Europe vascular closure device market in 2022, amassing US$ 223.65 million. It is projected to garner US$ 380.17 million by 2030 to expand at 6.9% CAGR during 2022-2030.

In terms of end user, the Europe vascular closure device market is categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment held 59.2% share of Europe vascular closure device market in 2022, amassing US$ 214.57 million. It is projected to garner US$ 367.94 million by 2030 to expand at 7.0% CAGR during 2022-2030.

Based on country, the Europe vascular closure device market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Rest of Europe held 26.5% share of Europe vascular closure device market in 2022, amassing US$ 96.18 million. It is projected to garner US$ 163.00 million by 2030 to expand at 6.8% CAGR during 2022-2030.

Key players operating in the Europe vascular closure device market are Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, Cordis Corp, ENDOCOR GmbH & CO KG, Haemonetics Corp, Medtronic Plc, Teleflex Inc, and Vasorum Ltd, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe vascular closure device market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Europe vascular closure device market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the vascular closure device market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Vascular Closure Device Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Cardiovascular Diseases
4.1.2 Burgeoning Demand for Minimally Invasive Devices
4.2 Market Restraints
4.2.1 Risk of Infection Related to Vascular Closure Devices
4.3 Market Opportunities
4.3.1 Untapped Potential of Emerging Economies
4.4 Future Trends
4.4.1 Strategic Activities by Manufacturers
4.5 Impact Analysis:
5. Vascular Closure Device Market – Europe Market Analysis
5.1 Europe Vascular Closure Device Market Revenue (US$ Mn), 2022 – 2030
6. Europe Vascular Closure Device Market – Revenue and Forecast to 2030 – by Product Type
6.1 Overview
6.2 Europe Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
6.3 Active Approximators
6.3.1 Overview
6.3.2 Active Approximators: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Active Approximators: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Passive Approximators
6.4.1 Overview
6.4.2 Passive Approximators: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Passive Approximators: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
6.5 External hemostatic devices
6.5.1 Overview
6.5.2 External hemostatic devices: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Vascular Closure Device Market – Revenue and Forecast to 2030 – by Access
7.1 Overview
7.2 Europe Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
7.3 Femoral Access
7.3.1 Overview
7.3.2 Femoral Access: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Radial Access
7.4.1 Overview
7.4.2 Radial Access: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Vascular Closure Device Market – Revenue and Forecast to 2030 – by Procedure
8.1 Overview
8.2 Europe Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
8.3 Interventional Cardiology
8.3.1 Overview
8.3.2 Interventional Cardiology: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Interventional Radiology
8.4.1 Overview
8.4.2 Interventional Radiology: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Endovascular Surgical
8.5.1 Overview
8.5.2 Endovascular Surgical: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Vascular Closure Device Market – Revenue and Forecast to 2030 – by End Users
9.1 Overview
9.2 Europe Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Center
9.4.1 Overview
9.4.2 Ambulatory Surgical Center: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Vascular Closure Device Market – Country Analysis
10.1.1.1 Europe Vascular Closure Device Market by Country
10.1.1.2 Germany
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Germany: Europe Vascular Closure Device Market, by Product Type
10.1.1.2.3.1 Germany: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.2.3.2 Germany: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.2.4 Germany: Europe Vascular Closure Device Market, by Access
10.1.1.2.5 Germany: Europe Vascular Closure Device Market, by Procedure
10.1.1.2.6 Germany: Europe Vascular Closure Device Market, by End Users
10.1.1.3 UK
10.1.1.3.1 Overview
10.1.1.3.2 UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 UK: Europe Vascular Closure Device Market, by Product Type
10.1.1.3.3.1 UK: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.3.3.2 UK: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.3.4 UK: Europe Vascular Closure Device Market, by Access
10.1.1.3.5 UK: Europe Vascular Closure Device Market, by Procedure
10.1.1.3.6 UK: Europe Vascular Closure Device Market, by End Users
10.1.1.4 France
10.1.1.4.1 Overview
10.1.1.4.2 France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 France: Europe Vascular Closure Device Market, by Product Type
10.1.1.4.3.1 France: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.4.3.2 France: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.4.4 France: Europe Vascular Closure Device Market, by Access
10.1.1.4.5 France: Europe Vascular Closure Device Market, by Procedure
10.1.1.4.6 France: Europe Vascular Closure Device Market, by End Users
10.1.1.5 Italy
10.1.1.5.1 Overview
10.1.1.5.2 Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Italy: Europe Vascular Closure Device Market, by Product Type
10.1.1.5.3.1 Italy: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.5.3.2 Italy: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.5.4 Italy: Europe Vascular Closure Device Market, by Access
10.1.1.5.5 Italy: Europe Vascular Closure Device Market, by Procedure
10.1.1.5.6 Italy: Europe Vascular Closure Device Market, by End Users
10.1.1.6 Spain
10.1.1.6.1 Overview
10.1.1.6.2 Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 Spain: Europe Vascular Closure Device Market, by Product Type
10.1.1.6.3.1 Spain: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.6.3.2 Spain: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.6.4 Spain: Europe Vascular Closure Device Market, by Access
10.1.1.6.5 Spain: Europe Vascular Closure Device Market, by Procedure
10.1.1.6.6 Spain: Europe Vascular Closure Device Market, by End Users
10.1.1.7 Rest of Europe
10.1.1.7.1 Overview
10.1.1.7.2 Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.7.3 Rest of Europe: Europe Vascular Closure Device Market, by Product Type
10.1.1.7.3.1 Rest of Europe: Europe Vascular Closure Device Market, by Active Approximators, 2020-2030 (US$ Million)
10.1.1.7.3.2 Rest of Europe: Europe Vascular Closure Device Market, by Passive Approximators , 2020-2030 (US$ Million)
10.1.1.7.4 Rest of Europe: Europe Vascular Closure Device Market, by Access
10.1.1.7.5 Rest of Europe: Europe Vascular Closure Device Market, by Procedure
10.1.1.7.6 Rest of Europe: Europe Vascular Closure Device Market, by End Users
11. Vascular Closure Device Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Vascular Closure Devices Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Cordis Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Vasorum Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Haemonetics Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Abbott Laboratories
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Becton Dickinson and Co
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Cardinal Health Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 ENDOCOR GmbH & CO KG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Medtronic Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teleflex Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Vascular Closure Device Market Segmentation
Table 2. Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 3. Germany: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
Table 4. Germany: Europe Vascular Closure Device Market, by Passive Approximators – Revenue and Forecast to 2030 (US$ Million)
Table 5. Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Access
Table 6. Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Procedure
Table 7. Germany: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – End Users
Table 8. UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 9. UK: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
Table 10. UK: Europe Vascular Closure Device Market, by Passive Approximators – Revenue and Forecast to 2030 (US$ Million)
Table 11. UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Access
Table 12. UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Procedure
Table 13. UK: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – End Users
Table 14. France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 15. France: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Europe Vascular Closure Device Market, by Passive Approximators – Revenue and Forecast to 2030 (US$ Million)
Table 17. France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Access
Table 18. France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Procedure
Table 19. France: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – End Users
Table 20. Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 21. Italy: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Europe Vascular Closure Device Market, by Passive Approximators – Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Access
Table 24. Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Procedure
Table 25. Italy: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – End Users
Table 26. Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 27. Spain: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain: Europe Vascular Closure Device Market, by Passive Approximators – Revenue and Forecast to 2030 (US$ Million)
Table 29. Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Access
Table 30. Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Procedure
Table 31. Spain: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – End Users
Table 32. Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 33. Rest of Europe: Europe Vascular Closure Device Market, by Active Approximators- Revenue and Forecast to 2030 (US$ Million)
Table 34. Rest of Europe: Europe Vascular Closure Device Market, by Passive Approximators – Revenue and Forecast to 2030 (US$ Million)
Table 35. Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Access
Table 36. Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – Procedure
Table 37. Rest of Europe: Europe Vascular Closure Device Market Revenue and Forecast to 2030 (US$ Mn) – End Users
Table 38. Recent Inorganic Growth Strategies in the Vascular Closure Devices Market
Table 39. Recent Organic Growth Strategies in the Vascular Closure Devices Market
Table 40. Glossary of Terms, Europe Vascular Closure Device Market

LIST OF FIGURES

Figure 1. Europe Vascular Closure Device Market Segmentation, By Country
Figure 2. Europe Vascular Closure Device Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Vascular Closure Device Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Europe Vascular Closure Device Market Revenue Share, by Product Type 2022 & 2030 (%)
Figure 6. Active Approximators: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Passive Approximators: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. External hemostatic devices: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Vascular Closure Device Market Revenue Share, by Access 2022 & 2030 (%)
Figure 10. Femoral Access: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Radial Access: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Vascular Closure Device Market Revenue Share, by Procedure 2022 & 2030 (%)
Figure 13. Interventional Cardiology: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Ceramic: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Endovascular Surgical: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Vascular Closure Device Market Revenue Share, by End Users 2022 & 2030 (%)
Figure 17. Hospitals: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Center: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Vascular Closure Device Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Vascular Closure Device Market, By key Country – Revenue (2022) (US$ Million)
Figure 21. Europe Vascular Closure Device Market, By Key Countries, 2022 And 2030 (%)
Figure 22. Germany: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
Figure 23. UK: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
Figure 24. France: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
Figure 25. Italy: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
Figure 26. Spain: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
Figure 27. Rest of Europe: Europe Vascular Closure Device Market Revenue And Forecast to 2030 (US$ Mn)
Figure 28. Growth Strategies in the Vascular Closure Devices Market

The List of Companies – Europe Vascular Closure Device Market

1. Cordis Corp
2. Vasorum Ltd
3. Haemonetics Corp
4. Abbott Laboratories
5. Becton Dickinson and Co
6. Cardinal Health Inc
7. ENDOCOR GmbH & CO KG
8. Medtronic Plc
9. Teleflex Inc

Reviews

There are no reviews yet.

Be the first to review “Europe Vascular Closure Device Market Forecast to 2030”